The technical evaluation for Dr Agarwals Eye Hospital reveals a complex interplay of indicators. The Moving Average Convergence Divergence (MACD) presents a bullish signal on the weekly timeframe, while the monthly MACD remains mildly bearish, indicating a nuanced momentum shift. Similarly, the Relative Strength Index (RSI) shows no significant signal weekly but turns bullish monthly, suggesting strengthening momentum over a longer horizon. Bollinger Bands align with a bullish outlook on both weekly and monthly charts, reinforcing the presence of upward price pressure.
Only 1% make it here. This Large Cap from the Gems, Jewellery And Watches sector passed our rigorous filters with flying colors. Be among the first few to spot this gem!
- Highest rated stock selection
- Multi-parameter screening cleared
- Large Cap quality pick
Additional technical indicators provide further insight. The Know Sure Thing (KST) oscillator is bullish on a weekly basis but mildly bearish monthly, reflecting short-term strength with some caution over longer periods. Dow Theory analysis shows a mildly bearish weekly trend and no clear monthly trend, indicating mixed signals from traditional market theory. Daily moving averages maintain a bullish posture, supporting the recent price gains. The stock’s daily price range today fluctuated between ₹5,200.00 and ₹5,295.00, with a slight day change of 0.15%, underscoring relatively stable trading activity.
From a broader market perspective, Dr Agarwals Eye Hospital’s returns present a varied picture. Over the past week, the stock returned 1.14%, outpacing the Sensex’s 0.96% gain. However, the one-month return shows a decline of 1.85% against the Sensex’s 0.86% rise. Year-to-date, the stock has recorded a negative return of 14.31%, contrasting with the Sensex’s positive 8.36%. Over longer horizons, the stock’s performance is more robust, with a five-year return of 2,161.96% significantly exceeding the Sensex’s 91.65%, and a ten-year return of 3,471.43% compared to the Sensex’s 232.28%. This long-term outperformance highlights the stock’s historical growth potential despite recent volatility.
Considering Dr Agarwals Eye Hospital ? Wait! SwitchER has found potentially better options in Hospital and beyond. Compare this small-cap with top-rated alternatives now!
- Better options discovered
- Hospital + beyond scope
- Top-rated alternatives ready
Dr Agarwals Eye Hospital’s market capitalisation grade stands at 3, reflecting its mid-tier valuation within the hospital sector. The recent adjustment in its mojo score to 68.0, accompanied by a change in mojo grade from Sell to Hold as of 29 August 2025, indicates a revision in evaluation based on evolving technical and market factors. The trigger for this technical parameter change was recorded on 19 November 2025, highlighting the dynamic nature of the stock’s momentum.
Investors analysing Dr Agarwals Eye Hospital should consider the mixed signals from various technical indicators alongside the stock’s historical performance relative to the broader market. While short-term momentum shows signs of bullishness, some monthly indicators suggest caution. The stock’s price remains well below its 52-week high of ₹7,300.00 but above the 52-week low of ₹3,500.00, indicating a wide trading range and potential volatility ahead.
Overall, the technical parameter changes for Dr Agarwals Eye Hospital reflect a shift towards more positive price momentum, supported by daily moving averages and weekly MACD signals. However, the presence of mildly bearish monthly indicators and mixed Dow Theory trends suggest that investors should monitor developments closely before making decisions. The stock’s long-term returns remain impressive, underscoring its potential as a significant player in the hospital sector.
Limited Time Only! Subscribe for Rs. 12,999 and get 1 Year of MojoOne + an Additional Year Completely FREE. Don't miss out on this exclusive offer. Claim Your Free Year →
